WebDec 31, 2024 · A clear-cut advantage for rhythm control has been difficult to demonstrate, but, in 2024, the EAST-AFNET 4 investigators reported results from a trial of 2800 patients (mean age, 70) with “early” AF (diagnosed within 1 year prior to enrollment; median, 36 days) who were randomized to rhythm control (i.e., antiarrhythmic drugs or ablation ... WebAug 30, 2024 · Early Rhythm Control Benefits Even Asymptomatic Patients with Atrial Fibrillation. Mark S. Link, MD, reviewing Willems S et al. Eur Heart J 2024 Aug 27. The strategy worked as well in patients without symptoms as in those with symptoms, according to a prespecified analysis from EAST-AFNET 4. In the EAST-AFNET 4 randomized trial ( …
Strategies for Rhythm Control in Atrial Fibrillation
WebOct 25, 2024 · Comment. In a meta-analysis of five earlier randomized trials comparing rhythm control vs. rate control strategies in a total of 5239 patients with persistent AF or AF that was considered likely to be recurrent, no significant difference was observed between the rate- and the rhythm-control groups regarding all-cause mortality, although … WebDec 4, 2024 · EAST-AFNET 4 confirmed that a strategy of initiating rhythm-control therapy in patients with early AF and concomitant cardiovascular conditions was associated with … newham community schools trust
More Evidence for Early Rhythm Control in Patients with New …
WebMar 14, 2024 · Timing of initiating AF treatment: EAST-AFNET 4 trial and other investigators have put forth a view that in comparison with rate control of AF, initiating early rhythm control, within 1-year of AF onset, decreases the risk of death from cardiovascular (CV) causes, ischemic stroke, heart failure (HF) admission, or acute myocardial infarction. 1, … WebApr 11, 2024 · Introduction. Atrial fibrillation (AF) is the most common arrhythmia and a heterogeneous mainly chronic disease associated with morbidity, heart failure, myocardial infarction, dementia, mortality, and decreased quality of life [1].In an era of increased AF prevalence, partly related to aging of our population but also improved health awareness … WebSep 22, 2024 · In 2024, the EAST-AFNET-4 trial called into question a rate-control strategy for higher-risk patients with minimally symptomatic or asymptomatic atrial fibrillation (AF); findings demonstrated that early rhythm control (within 12 months of AF diagnosis) improved cardiovascular outcomes ( NEJM JW Gen Med Oct 1 2024 and N Engl J Med … newham community learning trust